BCAX logo

BCAX

Bicara Therapeutics Inc.

$15.79
-$0.46(-2.83%)
53
Overall
60
Value
66
Tech
34
Quality
Market Cap
$932.48M
Volume
383.74K
52W Range
$7.80 - $28.09
Target Price
$32.14
Order:

Income Statement

MetricTrendChart
2023
Dec
2024
Dec
OPERATING EXPENSES
Operating Expenses
$39.9M$82.4M
Research & Development
$30.6M$63.6M
Research Expense
$30.6M$63.6M
Selling, General & Administrative
$9.3M$18.8M
General & Administrative Expenses
$9.3M$18.8M
Salaries & Wages
--$7.4M
Other Operating Expenses
--$82.4M
OPERATING INCOME
Operating income
$-39.9M$-82.4M
EBITDA
$-52.0M$-67.8M
NON-OPERATING ITEMS
Intinc
$1.3M$14.6M
Net Non-Operating Interest Income/Expense
$1.3M$14.6M
Other Income/Expense
$13.4M$-14.6M
Other Special Charges
--$14.6M
PRE-TAX INCOME
EBIT
$-52.0M$-67.8M
Pre-Tax Income
$-52.0M$-67.8M
INCOME TAX
Tax Provision
$5.0K$187.0K
NET INCOME
Net Income
$-52.0M$-68.0M
Net Income (Continuing Operations)
$-52.0M$-68.0M
Net Income (Discontinued Operations)
$-52.0M$-68.0M
Net Income (Common Stockholders)
$-52.0M$-68.0M
Normalized Income
$-38.2M$-67.1M
TOTALS
Total Expenses
$39.9M$82.4M
SHARE & EPS DATA
Average Shares Outstanding
$580.1K$16.8B
Average Shares Outstanding (Diluted)
$580.1K$16.8B
Shares Outstanding
$54.6M$54.5M
Basic EPS
$-89.61$-4.05
Basic EPS (Continuing Operations)
$-89.61$-4.05
Diluted EPS
$-89.61$-4.05
Diluted EPS (Continuing Operations)
$-89.61$-4.05
OTHER METRICS
Other Gand A
$9.3M$18.8M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BCAX$15.79-2.8%383.74K
3
4
5
6

Get Bicara Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.